Remogliflozin
Remogliflozin is for the treatment of non-alcoholic steatohepatitis and type 2 diabetes. It is a drug of the gliflozin.Reference standards of Remogliflozin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Remogliflozin - API Standards
[catalogue_number] => PA 18 1030000
[category_ids] => 82,78,70
[chemical_name] =>
[weight] => 450.53
[form] => C23H34N2O7
[cas] => 329045-45-6
[pslug] => 329045-45-6-remogliflozin-pa181030000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Remogliflozin - API Standards
Catalogue No.:PA 18 1030000
Molecular Formula : C23H34N2O7
Molecular Weight : 450.53
stdClass Object
(
[pname] => (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-((4-(4-isopropoxybenzyl)-5-methyl-1H-pyrazol-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol
[catalogue_number] => PA 18 1031000
[category_ids] => 82,78,70
[chemical_name] =>
[weight] => 408.45
[form] => C20H28N2O7
[cas] => 329044-79-3
[pslug] => 329044-79-3-2r-3s-4s-5r-6s-2-hydroxymethyl-6-4-4-isopropoxybenzyl-5-methyl-1h-pyrazol-3-yl-oxy-tetrahydro-2h-pyran-3-4-5-triol-pa181031000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-((4-(4-isopropoxybenzyl)-5-methyl-1H-pyrazol-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol
Catalogue No.:PA 18 1031000
Molecular Formula : C20H28N2O7
Molecular Weight : 408.45